'Chaotic' REACH processes need to be addressed – AmCham EU
US trade body urges Commission to make improvements
The chemicals industry and society are being damaged by the "very high level of uncertainty" brought about by REACH processes, the American Chamber of Commerce in Brussels (AmCham EU) says.
In its submission to the European Commission’s second REACH review, the organisation says despite efforts made by the EU executive, Echa and member states, the implementation of REACH processes "remains somewhat chaotic". And, it adds, this can lead to inconsistencies or contradictions.
AmCham EU is one of several industry groups, NGOs and public sector bodies, to submit comments to the consultation. The review's findings are due to be completed later this year.
It is "particularly difficult", it goes on, to see why the same substance would be targeted by different processes led by different member states. "We would encourage the Commission and Echa to clarify everyone’s obligations and rights."
It adds that "significant improvements" are needed in predictability to support investment in existing and new substances.
And in its general comments on the REACH review, the American Chemistry Council (ACC) also calls for simplified and improved implementation. It notes that "a perceived lack" of robust evaluation of hazard data – rather than risk – leads to substances essential for health, such as Vitamin D, being identified as hazards.
Both US bodies want improvements to guidance documents. The ACC says "more transparency" is needed and stakeholders should be given multiple opportunities to provide input into documents. AmCham EU says it is not clear whether industry comments are even considered in the final decisions.
The Commission and Echa should take on a more “"central role"in implementing REACH by consulting with registrants and other stakeholders for major substances, AmCham EU says.
It adds that it "deplores" significant regulations being advanced outside of REACH that "jeopardise the legitimacy of the entire REACH framework", citing developments to the occupational safety and health (Osh) directive and Classification, Labelling and Packaging (CLP) Regulation.
Overlaps between REACH and other EU legislation, ACC says, often lead to "inconsistencies and deadlocks", such as those between REACH and Osh. One example, AmCham EU says, is where Echa's risk assessment committee (Rac) and DG Employment's Scientific Committee on Occupational Exposure Limits (Scoel) "continuously apply different limit values" as their methodologies differ on the reprotoxic solvent 1-methyl-2-pyrrolidone (NMP).
Eye on enforcement
Compliance checks sometimes lead to "multi-year processes with no predictability of compliance", AmCham EU says. REACH restrictions, if not enforced, are a "de facto competitive advantage" for non-compliant European and third-country industries, it adds.
For example, the restriction on polycyclic aromatic hydrocarbons (PAHs) has meant that tyre companies manufacturing in Europe, including US ones, have spent more than €100m on research, development and testing for compliance and alternatives assessment, it says.
Competent authorities must be constantly updated on the most recent interpretation of the Regulation and apply guidelines agreed at EU level, AmCham EU says. And better training of enforcement officials and greater coordination between different departments of national competent authorities is needed.
2026-07-27
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Global Food Policy Shift 60-Day Rice Import Ban in Philippines EU Issues 5 Recalls on Chinese Exports in One Week
-
FDA Approves Precigen’s Papzimeos Immunotherapy 51 Percent of RRP Patients Avoid Surgery for One Year
-
“全球展会数据”功能上线公告 Announcement on the Launch of the “Global Exhibition Data” Function
-
South Korea’s Largest Petrochemical Hub Moves to Cut Cracker Capacity by 40%
-
The End of Hype: Europe’s Bio-stimulant Industry Faces a Science-First Reckoning by 2030
-
Jinggong Tech H1 Net Profit Soars 15 Percent Revenue Reaches 1.06 Billion Yuan Carbon Fiber Equipment Drives 59 Percent of Sales
-
Japan Tightens the Rules—Then Loosens Them: A Surprising Shift in Food Additive Policy
-
Parliamentary Panel Urges Expanded Price Controls as Dozens of Cancer Drugs Remain Unregulated
-
FDA Names Veteran Oncology Regulator Pazdur as Director of Drug Review Center
-
After Semaglutide Patent Expiry in India, the Price System Has Been Restructured as More Than 40 Drugmakers Enter the Competition
Recommend Reading
-
Syngenta Bee Pesticide Protest Shows the Pressure Building Around Crop Protection Giants
-
Glyphosate Faces New UK Pressure as EU Trade Alignment Returns to the Debate
-
FDA’s Review of BHT and ADA Signals a New Era for Food Additive Compliance
-
FDA’s Warning to Compounders Raises the Stakes for API and Excipient Suppliers
-
Four Fine Chemical Units of Huajin Aramco Project – HDPE, EO/EG, etc. – Reach Mechanical Completion
-
Acetophenone: Properties, Uses, and Applications
-
Warehouse Receipt Cancellation Fuels Market Sentiment, Driving Lithium Carbonate Prices Higher
-
Downstream Urgent Purchases Drive Acrylic Market to Decline
-
Styrene-Butadiene Rubber Market Shows Slight Upward Trend
-
Styrene-Butadiene Rubber Market Struggles to Find Direction